Actavis PLC (NYSE:ACT)

289.74
Delayed Data
As of May 01
 +6.88 / +2.43%
Today’s Change
193.00
Today|||52-Week Range
317.72
+12.56%
Year-to-Date

Today’s Trading

Previous close282.86
Today’s open285.17
Day’s range284.68 - 290.01
Volume2,628,461
Average volume (3 months)3,328,347
Market cap$113.8B
Dividend yield--
Data as of 4:03pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+26.04%
Earnings growth (next 5 years)+14.90%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.72

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.89+1.58%
GSKGlaxoSmithKline-0.18-0.39%
BMYBristol-Myers Squibb+0.93+1.46%
ABBVAbbVie-0.34-0.53%
Data as of 4:03pm ET, 05/01/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)$3.94
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers